Hello. I’m Dr Arefa Cassoobhoy, a practicing internist, Medscape advisor, and senior medical director for WebMD. Welcome to Medscape Morning Report, our 1-minute news story for primary care.
There may be some good news for people who suffer from migraine headaches. Another device is now FDA-approved for prevention, and it’s already used for treating acute pain from migraines. The Spring TMS device delivers single-pulse transcranial magnetic stimulation to the brains of chronic migraine sufferers.
According to a new study, daily prophylactic treatment for 3 months, which consists of four pulses twice a day, can reduce the number of headache days by almost one third.
The study included over 130 patients who experienced migraines on at least 4 days per month which lasted for 4 hours or more. The participants completed a 28-day headache diary before starting the 3-month protocol and reported a mean of about 9 headache days per month at baseline. After treatment, this dropped by 2.75 days.
What’s even more encouraging is that the technology has been used for years and has a good safety profile. Be on the lookout for this new option.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.